A single dose of respiratory syncytial virus vaccine was effective against infections and associated hospitalizations in veterans aged at least 60 years during the 2023-24 season.

Coinfection with RSV, REV, and MPV was significantly associated with treatment failure and prolonged treatment in children with viral LRTIs on respiratory support.

In a recent final analysis of a phase 3 trial, the bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccine maintained high efficacy and a favorable safety profile against RSV-associated ...

A spike in strep throat cases in Ashtabula County has led the Ashtabula County Health Department to spread information regarding the illness and several cases of associated scarlet fever, according to ...

Idaho has survived “Fools Spring” and the “Spring of Deception.” That means another one of Idaho’s unique seasons, “The ...

Among older adults in Spain, hospitalization rates from respiratory syncytial virus (RSV) infection increases progressively with age and is more likely among people with other health issues and ...